Video Series: Dr. Dotters-Katz weighs in on COVID-19 in pregnancy
Dr. Sarah Dotters-Katz is a maternal-fetal medicine specialist and obstetrician and gynecologist at Duke Health in Durham, N.C. One of her research interests is clinical infectious diseases and how they impact pregnancy.
Dr. Sarah Dotters-Katz is a maternal-fetal medicine specialist and obstetrician and gynecologist at Duke Health in Durham, N.C. One of her research interests is clinical infectious diseases and how they impact pregnancy.
In this video, Dr. Dotters-Katz discusses her perspective on COVID-19’s impact on pregnant patients with Senior Editor Angie DeRosa. Dotters-Katz also includes what she is seeing in her area of the United States. She has been very active in spreading her knowledge. She wrote a commentary in the April issue of Contemporary OB/GYN with Dr. Brenna Hughes, entitled, “COVID-19: The pathogen that will define the decade.”
She and Dr. Hughes also did a review recently for the American Journal of Perinatology, “Considerations for obstetric care during the COVID-19 pandemic,” in which they discussed the key points that COVID-19 severity in pregnancy is unclear and social distancing is the best protective mechanism. There is no clear evidence that vertical transmission exists. If a mother is positive, then mother/ baby separation avoids transmission. That article abstract can be found here.
Importance of reproductive health services for adolescents during the COVID-19 pandemic
October 30th 2024In a recent study, high rates of reproductive health service use were reported among adolescent mothers, indicating the benefits of this model for providing care when other options are unavailable.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
HP-hMG stimulation reduces OHSS risk in high responder patients
October 25th 2024A recent study found that highly purified human menotropin significantly lowers the risk of ovarian hyperstimulation syndrome compared to recombinant follicle stimulating hormone, highlighting the benefits of protocol individualization based on gonadotropin type.
Read More
Contemporary OB/GYN Senior Editor Angie DeRosa gets insight on the current state of COVID-19 from Christina Han, MD, division director of maternal-fetal medicine at the University of California, Los Angeles, and member of its COVID-19 task force. Han is an active member of the Society for Maternal-Fetal Medicine and discusses the issues on behalf of SMFM.
Listen
Racial disparities in high-risk endometrial subtype diagnoses reported
October 24th 2024In a recent study, Black patients were significantly more likely to present with high-risk endometrial subtypes for endometrial cancer, highlighting disparities in access to tumor next generation sequencing.
Read More
